Cargando…
上皮间质转化在非小细胞肺癌EGFR-TKIs耐药中的研究进展
Lung cancer is the one of the malignant tumor of the highest morbidity and mortality over the world, and non-small cell lung cancer (NSCLC) makes up about 80%. Nowadays, molecular targeted therapy has been the first-line treatment for NSCLC. Epidermal growth factor receptor-tyrosine kinase inhibitor...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318572/ https://www.ncbi.nlm.nih.gov/pubmed/30591098 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.12.08 |